Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Cholesterol-lowering drug given cancer all-clear

Full trial results and meta-analysis both contradict preliminary scare.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Peto, R. et al. N. Engl. J. Med. published online 2 September 2008 (doi:10.1056/NEJMsa0806603).

    Article  CAS  Google Scholar 

  2. Rossebø, A.B. et al. N. Engl. J. Med. published online 2 September 2008 (doi:10.1056/NEJMoa0804602).

    Article  Google Scholar 

  3. Drazen, J.M. et al. N. Engl. J. Med. published online 2 September 2008 (doi:10.1056/NEJMe0807200).

    Article  CAS  Google Scholar 

Download references

Authors

Related links

Related links

Related external links

New England Journal of Medicine

European Society of Cardiology congress

IMPROVE-IT

SHARP

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abbott, A. Cholesterol-lowering drug given cancer all-clear. Nature (2008). https://doi.org/10.1038/news.2008.1076

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2008.1076

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing